Android app Apple app link

Lilly invests $3 billion to expand Wisconsin plant as obesity drug demand soars

By CNBC   |   1 year ago
Lilly invests $3 billion to expand Wisconsin plant as obesity drug demand soars

Eli Lilly plans to invest $3 billion in expanding its Pleasant Prairie plant to meet high demand for weight-loss and diabetes drugs. The investment will boost production of Zepbound and diabetes treatments.

Read More

Did you find this insightful?

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.